Patents by Inventor Yakov Ron

Yakov Ron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11956257
    Abstract: A method for classifying domains to malware families includes identifying a corpus of malicious domains, identifying one or more suspicious domains, extracting a timeframe corresponding to the one or more suspicious domains, calculating a rank coefficient between the one or more suspicious domains and a current seed domain of the corpus of malicious domains, determining whether the rank correlation coefficient exceeds a rank threshold for the one or more suspicious domains, comparing a number of suspicious domains whose correlation coefficients exceed the rank threshold to a relation threshold, and responsive to determining the number of suspicious domains whose correlation coefficients exceed the rank threshold exceeds the relation threshold, applying a tag to the suspicious domains indicating that the one or more suspicious domains correspond to a same malware family as the current seed domain.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: April 9, 2024
    Assignee: International Business Machines Corporation
    Inventors: Aviv Ron, Alon Freund, Avishay Bartik, David Lazar, Yakov Shay-El Cohen
  • Patent number: 5688915
    Abstract: Long term culture of resting T lymphocytes. The present invention provides methods and compositions for maintaining resting, mature T lymphocytes (cells) for long term in the absence of mitogens, antigens, or stimulatory cytokines, in which the T cells maintaining their ability to respond to nitrogens and allogenic cells. T cells cultured under such conditions can be used as target cells for retroviral vector-mediated gene transfer and implemented in certain gene therapy applications. The culturing conditions described herein allow for the continuous availability of T lymphocytes for various pharmacological, diagnostic, gene therapy, and experimental purposes, and can be utilized for any application requiring non-stimulated T lymphocytes.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: November 18, 1997
    Assignee: The University of Medicine and Dentistry of New Jersey
    Inventors: Yakov Ron, Joseph Dougherty